Studies related to Symptoms of Parkinson's Disease and D-Serine

D-serine Adjuvant Treatment Alleviates Behavioural And Motor Symptoms In Parkinson's Disease

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 13
Sex Both Genders
Age Range 45-64, 65+
Notes for this study:
In persons with Parkinsons disease for at least 5 years and at stage II who were then given 30mg/kg D-serine daily for 6 weeks, it was found that the symptoms of Parkinsons as assessed by various measurement scales (UPDRS, SAS, and PNSS) and was well tolerated.